Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravenous ceftaroline with ceftriaxone in adults hospitalized with community-acquired bacterial pneumonia; completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Ceftaroline (intravenous) (ceftaroline)
• Ceftriaxone (intravenous) (ceftriaxone)

Snippet

Sponsor: Pfizer | Conditions: Community-Acquired Bacterial Pneumonia, Lung Infection of Individual Not Recently Hospitalized | Phase 3 | Status: COMPLETED | Results posted: 2014-09-23